NewsRoom Articles - Page 451 of 1425

ThursdayAug 05, 2021 1:22 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present Flagship PFN Program at 2021 Canaccord Genuity Virtual Growth Conference

The company will present an overview of business operations and its pipeline, including the Psilocybin-For-Neuropsychiatric Disorders (“PFN”) program for chronic pain and eating disorders The initial indication of lead drug candidate TRP-8802 is for fibromyalgia, but Tryp believes that psilocybin can be used for much more in the realm of unmet medical needs PFN’s development for its proprietary drug candidate, TRP-8803, focuses on increased efficacy, natural blood-brain barrier penetration, enhanced safety and toxicity profiles, reduced risk of abuse, and reduced risk of addiction Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a San Diego-based pharmaceuticals company, has joined the lineup of presenters…

ThursdayAug 05, 2021 1:16 pm

Grapefruit USA Inc. (GPFT) Signs Agreement with Leading Canadian Cannabis Manufacturer to Offer Game-Changing THC/CBD Cream

GPFT forms strategic alliance with 6PAK Solutions Inc Company working to achieve goal of launching Hourglass in Canada in the third quarter of 2021 Grapefruit’s patented Hourglass delivery cream system has fundamentally changed the way humans absorb cannabinoids In the United States, Grapefruit USA (OTCQB: GPFT) provides consumers with one of the most effective cannabis topical creams on the market. Now, through its partnership with 6PAK Solutions Inc., Grapefruit can offer its patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream in Canada too (https://nnw.fm/LFaaD). “We are very encouraged by 6PAK’s decision to form an alliance with Grapefruit to take…

ThursdayAug 05, 2021 12:13 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Marks Milestone Moment as First Psychedelic Biotech to Trade on NYSE American Exchange

Company announces official approval for its common shares to be listed, traded on NYSE American Cybin will commit resources to reach the broadest investor audience, accelerate efforts to position Cybin as sector leader Companies that list on NYSE American can leverage a wide range of advantages In an historic move, Cybin (NEO: CYBN) (NYSE American: CYBN) will become the first psychedelic biotech company to trade on the NYSE American LLC stock exchange (https://nnw.fm/mSDnJ). Cybin received official approval for its common shares to be listed and traded on NYSE American last week, and the company anticipates that shares will start trading…

ThursdayAug 05, 2021 12:05 pm

Brain Scientific Inc.’s (BRSF) Rapid Response EEG Devices Provide Cost-Effective Solution for Neurology Market

Patented NeuroCap(TM) and NeuroEEG(TM) devices can be used anywhere, ideal for clinical research labs, neurology clinics, urgent care clinics, emergency departments, ICUs, assisted living facilities, and nursing homes Current global market for EEG devices estimated at $956.1 million in 2020, expected to reach $1.6 billion revenue by 2026, CAGR of 8.7% between 2019-2026 Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company, focuses on developing cost-effective next-generation medical devices and software with the goal of modernizing and increasing accessibility to brain diagnostics for the rapidly growing neurology market. Brain Scientific’s patented NeuroCap(TM) and NeuroEEG(TM) devices are positioned to disrupt the expensive…

ThursdayAug 05, 2021 11:53 am

DSG Global Inc. (DSGT) Anticipates Immediate Income Potential Following Acquisition

Company enters into MOU to acquire auto import/export company Opportunities are to maintain excellence, leverage channels to grow sales DSG anticipates seeing impressive results soon after closing, plans to increase cash flow with positive revenue In a move that provides immediate sales opportunities, DSG Global (OTCQB: DSGT) announced that it has entered into a binding memorandum of understanding to acquire MTG Inc., an established automotive import/export company based in Ontario (https://nnw.fm/ZZjnY). MTG operates in Canada, the United States and Mexico and has extensive commercial fleet and retail connections throughout the global automotive industry. “We are acquiring a proven entity and…

ThursdayAug 05, 2021 9:00 am

Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments

NetworkNewsWire Editorial Coverage: A leading cause of death in the United States for men and women of most racial and ethnic groups, heart disease is a pervasive health challenge that destroys lives. The Centers for Disease Control and Prevention ("CDC") reports that one person dies every 36 seconds from cardiovascular disease. Treating the disease, as well as the conditions related to it such as high blood pressure, or hypertension, is a top priority for those in the medical space, and innovative companies are looking for ways to provide even more effective treatments. A leader in hypertension innovation, Lexaria Bioscience Corp. (NASDAQ:…

WednesdayAug 04, 2021 2:19 pm

AnPac Bio-Science Co., Ltd. Continues To Build On Its Success With What Many Thought Impossible – Multiple Cancer Screening

Summary After ten years of hard work, the pan-cancer screening concept and efforts led by AnPac Bio-Science Co., Ltd. (“AnPac Bio”; NASDAQ: ANPC) since 2010 is gaining market acceptance and traction. AnPac Bio’s cancer screening technology uses sensors fabricated by integrated circuit (IC) process to detect multiple cancers in the blood at the same time. According to US marketing research firm Frost-Sullivan, AnPac Bio ranked top three globally in terms of clinical and commercial test sample numbers in the space of new cancer detection technologies in 2019. In the next five years, AnPac Bio strives to become a global leader…

WednesdayAug 04, 2021 12:47 pm

DGE’S 2nd Electronic Trial Master File Forum To Showcase Leading Industry Faculty For Tips On TMF Technology For Successful Clinical Research

Online Livestreaming Event Date: August 16-17, 2021 Clinical researchers, medical managers, pharma companies, and life science professionals are invited to attend the 2nd Electronic Trial Master File (“eTMF”) Forum on August 16-17th, 2021. This 2-day event will offer a leading stage to learn the skills of integrated TMF technology for successful clinical research. Attendees will understand the intricacies of identifying the challenges and risks posed during clinical research. They will learn to identify how to protect the data gathered during the research trials, meeting regulatory requirements, preparing for audits, getting ready for inspections, and lucrative techniques for monitoring and filing…

WednesdayAug 04, 2021 12:05 pm

Grapefruit USA Inc. (GPFT) Expands into Billion-Dollar Market with New CBD Pet Tincture

Pet CBD industry projected to reach $1.7 billion by 2025 GPFT’s new pet CBD product targets two common dog, cat ailments: anxiety and joint pain Pets deserve the same relief that their owners experience with Grapefruit’s CBD products, says CEO Humans aren’t the only ones who may benefit from all that cannabidiol (“CBD”) offers. A recent Brightfield Group article reported that the pet CBD industry has experienced significant growth over the last several years, with Brightfield projecting an expected market valuation of more than $1.7 billion by 2025 (https://nnw.fm/GdwgX). Grapefruit USA (OTCQB: GPFT) is leveraging its expertise in the space…

WednesdayAug 04, 2021 11:45 am

American Cannabis Partners Success Lies in the Details and its Values

ACP operates in two states and has strategic plans in place to expand into two more by 2024 Partnerships have allowed the recreation of the exact soil conditions, growing supplements, water makeup, and environment of Orange Hill in Jamacia Junior Gordon, the Cultivation Manager of ACP, is an award-winning and highly sought after grower whose focus is primarily on plant health The privately-owned American Cannabis Partners ("ACP"), a large scale organic cannabis cultivation company, is headquartered in Northern California but also has a foothold in Michigan. Since its beginning in 2018, ACP has acquired 12 cannabis licenses, 20,000 sq. ft of…

Financial news and publishing for public and private companies

Contact us: 512.354.7000